Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Gemigliptin tartrate is a highly selective, reversible and competitive inhibitor of dipeptidyl peptidase-4 (DPP-4). It has an IC50 of 10.3 nM for human recombinant DPP-4. Gemigliptin tartrate exhibits potent anti-glycation properties.
Description | Gemigliptin tartrate is a highly selective, reversible and competitive inhibitor of dipeptidyl peptidase-4 (DPP-4). It has an IC50 of 10.3 nM for human recombinant DPP-4. Gemigliptin tartrate exhibits potent anti-glycation properties. |
Targets&IC50 | human recombinant DPP-4:10.3 nM |
In vitro | Gemigliptin tartrate inhibits the formation of AGE-BSA with IC50 of 11.69 mM[1]. Gemigliptin tartrate suppresses the cross-linking of preformed AGE-BSA with rat tail tendon collagen with an IC50 of 1.39 mM[1]. Gemigliptin tartrate is a competitive DPP-4 inhibitor with a Ki of 7.25 nM[2]. |
In vivo | Gemigliptin tartrate inhibits AGEs formation and AGE cross-links in vivo[1]. Gemigliptin tartrate dose-dependently inhibits plasma DPP-4 activity in rats, dogs, and monkeys[2]. |
Synonyms | LC15-0444 tartrate |
Molecular Weight | 639.45 |
Formula | C22H25F8N5O8 |
CAS No. | 1374639-74-3 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 90mg/ml(140.75mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gemigliptin Tartrate(911637-19-9 free base) 1374639-74-3 Proteases/Proteasome Ubiquitination DPP-4 Proteasome type Gemigliptin products mellitus peptidase-4 Gemigliptin Tartrate(911637 19 9 free base) dipeptidyl Gemigliptin Tartrate(911637199 free base) advanced diabetes LC15-0444 tartrate Inhibitor end glycation DPP Dipeptidyl Peptidase LC15-0444 AGE inhibit inhibitor